On March 23, 2023, Livanova Randomized 500Th Unipolar Patient Into Trial
March 24 (Reuters) - LivaNova PLC LIVN.O :
* LIVANOVA PLC - ON MARCH 23, 2023, LIVANOVA RANDOMIZED
500TH
UNIPOLAR PATIENT INTO TRIAL
* LIVANOVA PLC - UPON RECEIPT OF 12-MONTH FOLLOW-UP DATA FOR
ALL
500 PATIENTS, CO WILL CONDUCT A FINAL ANALYSIS FOR UNIPOLAR
COHORT
* LIVANOVA:INDEPENDENT STATISTICAL ANALYSIS COMMITTEE
ADVISED
TRIAL ENROLLMENT IN CO'S RECOVER DIFFICULT-TO-TREAT DEPRESSION
TRIAL SHOULD CONTINUE ON
Further company coverage: LIVN.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Livanova
See all newsAIM - Schedule One Update - TEK 4 Holdco Limited
Competition and Mkts - Merger Update: NRG Fleet / Specialist Fleet
LivaNova PLC reports results for the quarter ended June 30 - Earnings Summary
UK's LivaNova Q2 revenue beats estimates; lifts 2026 outlook
Brief: Livanova Demonstrates 84.5% Cumulative Response Rate With Polysync Programming In OSPREY Study